Citurgia Biochemicals Ltd.

•

citurgiabiochemicals.comBSE: -NSE: CITURGIBIO

Market Cap₹ 1,421 Cr.

Current Price

High / Low—

Stock P/E0.0

Book Value₹ -1

Price to Book-4.61

Dividend Yield0.00 %

ROCE-1964.7 %

ROE0.0 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence

55%

View full sector analysis →

PROS

Company is almost debt free

CONS

Net worth is negative - accumulated losses have eroded equity
Company is loss-making at the operating / net level
Operating cash flow has been negative in recent years
Interest coverage is weak at -2681.7x - earnings barely cover interest
Company has a low return on capital employed of -725.4%
Company has a low return on equity of 0.0% over last 3 years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SOLARINDS	21410.70	97.29	193745.54	0.05	666.37	88.98	3668.20	70.26	38.16	27.91
2.	PIDILITIND	1632.00	62.71	166117.97	1.32	8835.10	1202.86	45515.50	1112.74	32.38	26.28
3.	SRF	2605.00	35.72	77218.67	0.35	758.87	75.53	5033.26	34.63	14.21	24.57
4.	FLUOROCHEM	4691.60	83.80	51537.23	0.06	219.00	19.02	1588.00	23.97	9.58	26.83
5.	NAVINFLUOR	8697.20	56.51	44623.69	0.17	243.31	107.67	1045.08	44.07	21.39	34.17
6.	GODREJIND	1155.90	33.12	38936.61	0.00	523.36	-27.85	5448.09	22.16	10.64	12.82
7.	DEEPAKNTR	1727.25	30.08	23558.49	0.43	345.01	207.36	2577.60	36.39	11.58	20.96
8.	AETHER	1656.35	93.47	21984.38	0.00	62.75	33.45	326.56	27.49	11.65	31.47
9.	ATUL	6465.50	23.93	19035.57	0.46	253.93	91.85	1847.95	25.03	15.05	21.41
10.	AARTIIND	501.75	34.27	18199.81	0.20	155.00	260.47	2387.00	42.42	6.95	16.00
11.	DEEPAKFERT	1356.30	17.46	17179.29	0.74	490.04	100.95	3256.26	22.47	12.12	25.96
12.	CITURGIBIO	107.60	0.00	1421.35	0.00	-0.08	-2.50	0.00	—	-1964.73	—

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Profit	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
OPM %	—	—	—	—	—	—	—	—	—	—	—	—	—
	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit before Tax	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Tax %	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Net Profit	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	1
Operating Profit	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-1
OPM %	—	—	—	—	—	—	—	—	—	—	—
	0	0	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1	0	0	0	0	0	0	0	0	0	0
Profit before Tax	-1	-1	-1	-1	-0	-1	-0	-0	-0	-0	-1
Tax %	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Net Profit	-1	-1	-1	-1	-0	-1	-0	-0	-0	-0	-1
EPS	0.00	-0.20	0.00	-0.21	-0.15	-0.23	-0.15	-0.17	-0.18	-0.16	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: -22%
3 Years:: -2%
1 Year:: -48%

RETURN ON EQUITY

10 Years:: 0%
5 Years:: 0%
3 Years:: 0%
Last Year:: 0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	26	26	26	26	26	26	26	26	26	26
	-32	-32	-33	-33	-34	-34	-35	-35	-35	-36
	5	5	7	7	7	7	7	7	7	7
Trade Payables	4	4	4	4	4	4	4	4	4	4
	8	9	9	9	9	9	9	9	10	10
Total Liabilities	12	12	13	12	12	12	11	11	11	11
	3	3	2	2	2	2	1	1	1	1
	6	7	8	8	8	8	8	8	8	8
	2	2	2	2	2	2	2	2	2	2
Total Assets	12	12	13	12	12	12	11	11	11	11

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-0	-1	-1	-0	-0	-0	-0	-0	-0	-0
Cash from Investing	0	0	-0	0	0	0	0	0	-0	0
Cash from Financing	0	1	1	0	0	0	0	0	0	0
	-0	0	-0	-0	-0	0	-0	0	0	0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	-0.25	-0.20	-0.21	-0.21	-0.15	-0.23	-0.15	-0.17	-0.18	-0.16
Book Value (₹)	-1.93	-2.13	-2.34	-2.55	-2.70	-2.93	-3.09	-3.25	-3.43	-3.59
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	-0.01	-0.01	-0.01	-0.09	-0.05	-0.14	-0.07	-0.08	-0.09	-0.07
PROFITABILITY
Operating Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROE %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROCE %	-29.60%	-27.18%	-23.11%	-22.39%	-19.33%	-39.64%	-38.82%	-67.22%	-144.16%	-1964.73%
	-5.83%	-4.55%	-4.48%	-4.46%	-3.26%	-5.19%	-3.51%	-3.86%	-4.28%	-3.88%
EFFICIENCY
Debtor Days	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0
FINANCIAL HEALTH
Debt to Equity (x)	-0.88x	-0.92x	-1.04x	-0.96x	-0.91x	-0.84x	-0.80x	-0.76x	-0.75x	-0.72x
Interest Coverage (x)	0.00x	0.00x	-4754.56x	-613.60x	-231.93x	-2016.36x	0.00x	-4564.75x	-7093.47x	-2681.66x
	0.80x	0.89x	1.02x	1.00x	0.99x	0.97x	0.94x	0.93x	0.92x	0.91x
GROWTH
Revenue Growth %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Profit Growth %	10.53%	35.92%	-75.82%	-31.68%	50.93%	-216.68%	52.14%	-17.92%	-18.72%	21.05%
Net Profit Growth %	13.01%	19.19%	-3.60%	-1.32%	29.47%	-54.45%	33.96%	-7.94%	-9.03%	11.04%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-9.02%	11.06%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	-132.40x	-167.94x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	99.67	99.67	99.67	99.67	99.36	99.36	99.36	99.36	99.36
FIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public	0.32	0.32	0.32	0.32	0.64	0.64	0.64	0.64	0.64

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for CITURGIBIO

Loading news…

🤖

AI Stock Analyst

Citurgia Biochemicals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account